Hemodynamic effects of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: The prospective, randomized IABP shock trial

Shock

Volumn 37, Issue 4, 2012, Pages 378-384

  Prondzinsky, Roland ^a   Unverzagt, Susanne ^a   Russ, Martin ^a   Lemm, Henning ^a   Swyter, Michael ^a   Wegener, Nikolas ^a   Buerke, Ute ^a   Raaz, Uwe ^a   Ebelt, Henning ^a   Schlitt, Axel ^a   Heinroth, Konstantin ^a   Haerting, Johannes ^a   Werdan, Karl ^a   Buerke, Michael ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

acute myocardial infarction; cardiogenic shock; counterpulsation; Hemodynamic effects; intra aortic balloon pump

Indexed keywords

DOBUTAMINE; HYPERTENSIVE AGENT; INOTROPIC AGENT; NORADRENALIN;

ACUTE HEART INFARCTION; ADULT; AGED; AORTA BALLOON; ARTICLE; CARDIOGENIC SHOCK; CLINICAL ARTICLE; CONTROLLED STUDY; COUNTERPULSATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE FUNCTION; HEART OUTPUT; HEART RATE; HEART STROKE VOLUME; HEART VENTRICLE TACHYCARDIA; HEMODYNAMICS; HUMAN; MALE; MEAN ARTERIAL PRESSURE; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; PULMONARY ARTERY OCCLUSION PRESSURE; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYSTEMIC VASCULAR RESISTANCE; THERAPY EFFECT; URINE VOLUME; VASCULAR RESISTANCE;

AGED; FEMALE; HEMODYNAMICS; HUMANS; INTRA-AORTIC BALLOON PUMPING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; SHOCK, CARDIOGENIC;

EID: 84858795026     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e31824a67af     Document Type: Article

References (34)

1. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, et al.: Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize Occluded Coronaries for cardiogenic shocK. N Engl J Med 341:625-634, 1999.
2. Hochman JS, Sleeper LA, White HD, Dzavik V, Wong SC, Menon V, Webb JG, Steingart R, Picard MH, Menegus MA, et al.: One-year survival following early revascularization for cardiogenic shock. JAMA 285:190-192, 2001. (Pubitemid 32048521)
3. Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, Hochman JS, Krumholz HM, Lamas GA, Mullany CJ, et al.: 2007 Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 51:210-247, 2008.
4. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, et al.: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarctionVexecutive summary. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol 44:671-719, 2004.
5. Moulopoulos S, Stamatelopoulos S, Petrou P: Intraaortic balloon assistance in intractable cardiogenic shock. Eur Heart J 7:396-403, 1986. (Pubitemid 16120798)
6. Sanborn TA, Sleeper LA, Bates ER, Jacobs AK, Boland J, French JK, Dens J, Dzavik V, Palmeri ST, Webb JG, et al.: Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol 36:1123-1129, 2000.
7. Ohman EM, Nanas J, Stomel RJ, Leesar MA, Nielsen DW, O'Dea D, Rogers FJ, Harber D, Hudson MP, Fraulo E, et al.: Thrombolysis and counterpulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: results of the TACTICS Trial. J Thromb Thrombolysis 19:33-39, 2005. (Pubitemid 40959212)
8. Anderson RD, Ohman EM, Holmes Jr DR, Col J, Stebbins AL, Bates ER: Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-1 study. J Am Coll Cardiol 30: 708-715, 1997. (Pubitemid 27397651)
9. Barron HV, Every NR, Parsons LS, Angeja B, Goldberg RJ, Gore JM, Chou TM: The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. Am Heart J 141:933-939, 2001.
10. Prondzinsky R, Lemm H, Swyter M, Wegener N, Unverzagt S, Carter J, Russ M, Schlitt A, Buerke U, Christoph A, et al.: Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shockVthe prospective, randomized IABP SHOCK trial for attenuation of multi-organ dysfunction syndrome. Crit Care Med 38:152-160, 2010.
11. Jeger RV, Harkness SM, Ramanathan K, Buller CE, Pfisterer ME, Sleeper LA, Hochman JS, Shock Investigators: Emergency revascularization in patients with cardiogenic shock on admission: a report from the SHOCK trial and registry. Eur Heart J 27:664-670, 2006.
12. Hochman JS, Sleeper LA, Webb JG, Dzavik V, Buller CE, Aylward P, Col J, White HD, Shock Investigators: Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA 295: 2511-2515, 2006. (Pubitemid 43854966)
13. Hollenberg SM, Ahrens TS, Annane D, Astiz ME, Chalfin DB, Dasta JF, Heard SO, Martin C, Napolitano LM, Susla GM, et al.: Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med 32: 1928-1948, 2004. (Pubitemid 39202372)
14. Joulin O, Petillot P, Labalette M, Lancel S, Neviere R: Cytokine profile of human septic shock serum inducing cardiomyocyte contractile dysfunction. Physiol Res 56:291-297, 2007.
15. Buerke M, Weyrich AS, Zheng Z, Gaeta FC, Forrest MJ, Lefer AM: Sialyl LewisxYcontaining oligosaccharide attenuates myocardial reperfusion injury in cats. J Clin Invest 93:1140-1148, 1994.
16. Kovack PJ, Rasak MA, Bates ER, Ohman EM, Stomel RJ: Thrombolysis plus aortic counterpulsation: improved survival in patients who present to community hospitals with cardiogenic shock. J Am Coll Cardiol 29:1454-1458, 1997. (Pubitemid 27274744)
17. Sjauw KD, Engstrom AE, Vis MM, van der Schaaf RJ, Baan J Jr, Koch KT, de Winter RJ, Piek JJ, Tijssen JG, Henriques JP: A systematic review and metaanalysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J 30:459-468, 2009.
18. Babaev A, Frederick PD, Pasta DJ, Every N, Sichrovsky T, Hochman JS, Shock Investigators: Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 294:448-454, 2005. (Pubitemid 41124177)
19. Stone GW, Marsalese D, Brodie BR, Griffin JJ, Donohue B, Costantini C, Balestrini C, Wharton T, Esente P, Spain M, et al.: A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. Second Primary Angioplasty in Myocardial Infarction (PAMI-II) Trial Investigators. J Am Coll Cardiol 29:1459-1467, 1997. (Pubitemid 27272437)
20. Stone GW, Ohman EM, Miller MF, Joseph DL, Christenson JT, Cohen M, Urban PM, Reddy RC, Freedman RJ, Staman KL: Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: the Benchmark Registry. J Am Coll Cardiol 41:1940-1945, 2003. (Pubitemid 36677111)
21. Santa-Cruz RA, Cohen MG, Ohman EM: Aortic counterpulsation: a review of the hemodynamic effects and indications for use. Catheter Cardiovasc Interv 67:68-77, 2006. (Pubitemid 43062612)
22. Kern MJ, Aguirre F, Bach R, Donohue T, Siegel R, Segal J: Augmentation of coronary blood flow by intra-aortic balloon pumping in patients after coronary angioplasty. Circulation 87:500-511, 1993. (Pubitemid 23040920)
23. Vijayalakshmi K, Kunadian B, Whittaker VJ, Wright RA, Hall JA, Sutton A, Muir D, de Belder MA: Intra-aortic counterpulsation does not improve coronary flow early after PCI in a high-risk group of patients: observations from a randomized trial to explore its mode of action. J Invasive Cardiol 19: 339-346, 2007. (Pubitemid 47290400)
24. Nanas JN, Moulopoulos SD: Counterpulsation: historical background, technical improvements, hemodynamic and metabolic effects. Cardiology 84:156-167, 1994. (Pubitemid 24087073)
25. Torchiana DF, Hirsch G, Buckley MJ, Hahn C, Allyn JW, Akins CW, Drake JF, Newell JB, Austen WG: Intraaortic balloon pumping for cardiac support: trends in practice and outcome, 1968 to 1995. J Thorac Cardiovasc Surg 113: 758-764, 1997.
26. Kern MJ, Aguirre FV, Tatineni S, Penick D, Serota H, Donohue T, Walter K: Enhanced coronary blood flow velocity during intraaortic balloon counterpulsation in critically ill patients. J Am Coll Cardiol 21:359-368, 1993. (Pubitemid 23047918)
27. Ishihara M, Sato H, Tateishi H, Kawagoe T, Muraoka Y, Yoshimura M: Effects of intraaortic balloon pumping on coronary hemodynamics after coronary angioplasty in patients with acute myocardial infarction. Am Heart J 124:1133-1138, 1992.
28. Piper RD, Li FY, Myers ML, Sibbald WJ: Effects of isoproterenol on myocardial structure and function in septic rats. J Appl Physiol 86:993-1001, 1999. (Pubitemid 29118023)
29. Karlsberg RP, Cryer PE, Roberts RR: Serum plasma catecholamine response early in the course of myocardial infarction. Relation to infarct extent and mortality. Am Heart J 102:24-29, 1981. (Pubitemid 11086984)
30. Loeb HS, Bredakis J, Gunner RM: Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure. Circulation 55:375-378, 1977.
31. Russ MA, Prondzinsky R, Christoph A, Schlitt A, Buerke U, Soffker G, Lemm H, Swyter M, Wegener N, Winkler M, et al.: Hemodynamic improvement following levosimendan treatment in patients with acute myocardial infarction and cardiogenic shock. Crit Care Med 35:2732-2739, 2007. (Pubitemid 350175769)
32. Russ MA, Prondzinsky R, Carter JM, Schlitt A, Ebelt H, Schmidt H, Lemm H, Heinroth K, Soeffker G, Winkler M, et al.: Right ventricular function in myocardial infarction complicated by cardiogenic shock: improvement with levosimendan. Crit Care Med 37:3017-3023, 2009.
33. Fincke R, Hochman JS, Lowe AM, Menon V, Slater JN, Webb JG, LeJemtel TH, Cotter G: Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry. J Am Coll Cardiol 44:340-348, 2004. (Pubitemid 38950593)
34. Mendoza DD, Cooper HA, Panza JA: Cardiac power output predicts mortality across a broad spectrum of patients with acute cardiac disease. Am Heart J 153:366-370, 2007. (Pubitemid 46328753)